BRPI1011522A2 - compostos de indol substituídos como moduladores receptor de bradiquinina 1. - Google Patents
compostos de indol substituídos como moduladores receptor de bradiquinina 1.Info
- Publication number
- BRPI1011522A2 BRPI1011522A2 BRPI1011522A BRPI1011522A BRPI1011522A2 BR PI1011522 A2 BRPI1011522 A2 BR PI1011522A2 BR PI1011522 A BRPI1011522 A BR PI1011522A BR PI1011522 A BRPI1011522 A BR PI1011522A BR PI1011522 A2 BRPI1011522 A2 BR PI1011522A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor modulators
- substituted indole
- indole compounds
- bradykinin receptor
- bradykinin
- Prior art date
Links
- 102000010183 Bradykinin receptor Human genes 0.000 title 1
- 108050001736 Bradykinin receptor Proteins 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09001488 | 2009-02-04 | ||
| PCT/EP2010/000630 WO2010089084A1 (de) | 2009-02-04 | 2010-02-02 | Substituierte indol-verbindungen als bradykinin rezeptor 1 modulatoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1011522A2 true BRPI1011522A2 (pt) | 2016-03-29 |
Family
ID=40839539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1011522A BRPI1011522A2 (pt) | 2009-02-04 | 2010-02-02 | compostos de indol substituídos como moduladores receptor de bradiquinina 1. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8492559B2 (pt) |
| EP (1) | EP2393803A1 (pt) |
| JP (1) | JP2012516860A (pt) |
| AR (1) | AR074967A1 (pt) |
| AU (1) | AU2010211251A1 (pt) |
| BR (1) | BRPI1011522A2 (pt) |
| CA (1) | CA2751402A1 (pt) |
| MX (1) | MX2011008126A (pt) |
| TW (1) | TW201031665A (pt) |
| WO (1) | WO2010089084A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2825542B1 (en) | 2012-03-16 | 2016-09-14 | Vitae Pharmaceuticals, Inc. | Liver x receptor modulators |
| KR102069912B1 (ko) | 2012-03-16 | 2020-01-23 | 비타이 파마슈티컬즈, 엘엘씨 | 간 x 수용체 조절제 |
| CN104945416B (zh) * | 2014-03-24 | 2017-11-17 | 中国科学院上海药物研究所 | 一类螺异噁唑啉衍生物、其制备方法及医药用途 |
| GB201519195D0 (en) * | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP Receptor Antagonists |
| CN112573978B (zh) * | 2019-09-30 | 2022-05-13 | 北京大学 | 一种芳基卤化物的高效卤化合成方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6147106A (en) * | 1997-08-20 | 2000-11-14 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| JP2002541145A (ja) * | 1999-04-02 | 2002-12-03 | ニューロゲン コーポレイション | アリールおよびヘテロアリール縮合アミノアルキル−イミダゾール誘導体:ブラジキニンb2受容体選択性モジュレータ |
| GB0017256D0 (en) | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
| AU2003261951A1 (en) * | 2002-09-06 | 2004-03-29 | D. Western Therapeutics Institute | Medicinal composition and method for treating malignant tumor and utilization thereof |
| EP1600447A1 (en) | 2004-05-28 | 2005-11-30 | Neuropharma S.A.U. | Butyrylcholinesterase selective inhibitors |
| US20060128765A1 (en) * | 2004-12-10 | 2006-06-15 | Wood Michael R | 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| WO2007101007A2 (en) | 2006-02-23 | 2007-09-07 | Neurogen Corporation | Aryl sulfonyl heterocycles |
| WO2007140383A2 (en) | 2006-05-30 | 2007-12-06 | Neurogen Corporation | Spirocyclic sulfonamides and related compounds |
| WO2008033739A2 (en) * | 2006-09-12 | 2008-03-20 | Neurogen Corporation | Benzimidazole carboxamide derivatives |
| AU2007304475B2 (en) | 2006-09-29 | 2012-07-26 | Grunenthal Gmbh | Substituted sulfonamide derivatives |
| WO2008046573A1 (de) | 2006-10-16 | 2008-04-24 | Grünenthal GmbH | Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren |
-
2010
- 2010-01-15 TW TW099101012A patent/TW201031665A/zh unknown
- 2010-01-29 AR ARP100100246A patent/AR074967A1/es not_active Application Discontinuation
- 2010-02-02 WO PCT/EP2010/000630 patent/WO2010089084A1/de not_active Ceased
- 2010-02-02 JP JP2011548590A patent/JP2012516860A/ja not_active Withdrawn
- 2010-02-02 BR BRPI1011522A patent/BRPI1011522A2/pt not_active IP Right Cessation
- 2010-02-02 CA CA2751402A patent/CA2751402A1/en not_active Abandoned
- 2010-02-02 MX MX2011008126A patent/MX2011008126A/es not_active Application Discontinuation
- 2010-02-02 AU AU2010211251A patent/AU2010211251A1/en not_active Abandoned
- 2010-02-02 EP EP10703016A patent/EP2393803A1/de not_active Withdrawn
- 2010-02-03 US US12/699,451 patent/US8492559B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20100222324A1 (en) | 2010-09-02 |
| MX2011008126A (es) | 2011-08-17 |
| CA2751402A1 (en) | 2010-08-12 |
| AR074967A1 (es) | 2011-02-23 |
| TW201031665A (en) | 2010-09-01 |
| US8492559B2 (en) | 2013-07-23 |
| JP2012516860A (ja) | 2012-07-26 |
| AU2010211251A1 (en) | 2011-09-29 |
| WO2010089084A1 (de) | 2010-08-12 |
| EP2393803A1 (de) | 2011-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2643164T3 (es) | Indol 7-sustituido como inhibidores de Mcl-1 | |
| BRPI1008939A2 (pt) | 2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3. | |
| BRPI0910585A2 (pt) | indóis como moduladores de receptor de aceticolina nicotínica do subtipo alfa-7 | |
| DE602008003116D1 (de) | 8-oxychinolinderivate als modulatoren des bradykinin-b2-rezeptors | |
| BRPI0914942A2 (pt) | Compostos de oxindol | |
| BRPI0715324A2 (pt) | Composto de indol | |
| BRPI1008855A2 (pt) | derivados de indol como agentes anticâncer | |
| DK2493858T3 (da) | Androgenreceptor modulerende forbindelser. | |
| BR112012006630A2 (pt) | derivados em indol como moduladores dos canais de cálcio ativados para liberação de cálcio (crac) | |
| BRPI0909375A2 (pt) | Moduladores de receptores de quimiocinas | |
| IL207684A0 (en) | Substituted indole derivatives | |
| BRPI0912196A2 (pt) | pirazóis trissubstituídos como moduladores do receptor de acetilcolina. | |
| BRPI1008949A2 (pt) | Cetoenóis haloalquilmetilenóxi-fenil-substituídos. | |
| BR112012004718A2 (pt) | compostos como moduladores de tirosina quinase | |
| BR112013015234A2 (pt) | derivados fosforosos como moduladores de receptor de quimiocina | |
| BRPI0809221A2 (pt) | indol carboxamidas como inibidores de ikk2 | |
| BRPI0919898A2 (pt) | 4,5,6,7-tetra-hidrotienopiridinas substituídas como moduladores de kcnq2/3 | |
| BRPI0818338A2 (pt) | Composto de pirimidil indolina | |
| CU23870B1 (es) | Derivados de ciclopropilamida como moduladores h3 | |
| BR112013013037A2 (pt) | derivados de indol como moduladores dos receptores de s1p | |
| BRPI0920247A2 (pt) | benzimidazóis heterocíclicos como moduladores de trpm8. | |
| BRPI1009428A2 (pt) | 3-aminoisoxazolopiridina substituída como moduladores de kcnq2/3 | |
| CU23899B1 (es) | Benzotiazoles como moduladores del receptor de grelina | |
| BRPI1009519A2 (pt) | 3-amino-2-mercaptoquinolina substituída como modulador de kcnq2/3. | |
| BRPI1008963A2 (pt) | 2-mercapto-3-aminopiridina substituída como moduladores de kcnq2/3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2373 DE 28-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |